GCAP2 Inhibitors
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
L-NG-Nitroarginine Methyl Ester (L-NAME) | 51298-62-5 | sc-200333 sc-200333A sc-200333B | 1 g 5 g 25 g | $48.00 $107.00 $328.00 | 45 | |
Inhibits nitric oxide synthase (NOS), which can indirectly affect guanylate cyclase activity, and hence GCAP2 function. | ||||||
ODQ | 41443-28-1 | sc-200325 sc-200325A | 10 mg 50 mg | $78.00 $222.00 | 13 | |
A soluble guanylate cyclase inhibitor. By inhibiting guanylate cyclase, ODQ can indirectly modulate the actions of GCAP2. | ||||||
NS 2028 | 204326-43-2 | sc-202743 | 5 mg | $149.00 | 1 | |
Specifically inhibits guanylate cyclase, which can have repercussions on GCAP2-mediated signaling. | ||||||
Methylene blue | 61-73-4 | sc-215381B sc-215381 sc-215381A | 25 g 100 g 500 g | $43.00 $104.00 $328.00 | 3 | |
Acts on guanylate cyclase, reducing its activity and hence indirectly influencing GCAP2. | ||||||
LY 83583 | 91300-60-6 | sc-200314 sc-200314A | 5 mg 25 mg | $82.00 $230.00 | 3 | |
Inhibits guanylate cyclase activity, thereby having potential indirect effects on GCAP2 function. | ||||||
KT5823 | 126643-37-6 | sc-3534 sc-3534A sc-3534B | 100 µg 1 mg 5 mg | $182.00 $1228.00 $4895.00 | 21 | |
Protein kinase G inhibitor. As GCAP2's role in guanylate cyclase activation can influence cGMP and PKG activity, inhibiting PKG can indirectly influence GCAP2-associated signaling. | ||||||
Vinpocetine | 42971-09-5 | sc-201204 sc-201204A sc-201204B | 20 mg 100 mg 15 g | $55.00 $214.00 $2400.00 | 4 | |
Acts as a PDE1 inhibitor, preventing the breakdown of cGMP. This can influence the balance of cGMP in the cell and indirectly modulate GCAP2's function. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
A PDE5 inhibitor which affects cGMP levels. By modulating cGMP concentrations, Zaprinast can indirectly influence GCAP2-associated functions. | ||||||
Ibudilast | 50847-11-5 | sc-203080 | 10 mg | $218.00 | 1 | |
PDE4 inhibitor, leading to increased cGMP levels. This can indirectly influence GCAP2 functions within the cell. | ||||||